Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Li, Wen Fei ^a   Liu, Na ^a   Cui, Rui Xue ^a   He, Qing Mei ^a   Chen, Mo ^a   Jiang, Ning ^a   Sun, Ying ^a   Zeng, Jing ^a   Liu, Li Zhi ^a   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Biomarker; MTA1; Nasopharyngeal carcinoma; Prognosis

Indexed keywords

CISPLATIN; FLUOROURACIL; METASTASIS ASSOCIATED PROTEIN 1; ONCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION;

CELL NUCLEUS; COMBINED MODALITY THERAPY; FEMALE; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; PROGNOSIS; REPRESSOR PROTEINS; SURVIVAL RATE;

EID: 84862222338     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-78     Document Type: Article

References (32)

1. Globocan 2008 cancer incidence and mortality worldwide in 2008. Globocan 2008., http://globocan.iarc.fr/
2. Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys 2011, 80:661-668. 10.1016/j.ijrobp.2010.03.024, 20643517.
3. Cho W. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007, 6:1. 1774581, 17199893.
4. Kumar R, Wang RA, Bagheri-Yarmand R. Emerging roles of MTA family members in human cancers. Semin Oncol 2003, 30:30-37.
5. Toh Y, Nicolson GL. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 2009, 26:215-227. 10.1007/s10585-008-9233-8, 19116762.
6. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998, 2:851-861. 10.1016/S1097-2765(00)80299-3, 9885572.
7. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 2004, 1677:52-57. 10.1016/j.bbaexp.2003.10.010, 15020045.
8. Toh Y, Pencil SD, Nicolson GL. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 1994, 269:22958-22963.
9. Nawa A, Nishimori K, Lin P, Maki Y, Moue K, Sawada H, Toh Y, Fumitaka K, Nicolson GL. Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem 2000, 79:202-212. 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L, 10967548.
10. Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, Moustafa A. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 2003, 20:19-24. 10.1023/A:1022534217769, 12650603.
11. Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y, Nicolson GL, Sugimachi K. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 1997, 74:459-463. 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4, 9291440.
12. Toh Y, Kuwano H, Mori M, Nicolson GL, Sugimachi K. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 1999, 79:1723-1726. 10.1038/sj.bjc.6690274, 2362784, 10206283.
13. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, Shapiro GI, Gschwend JE, Hautmann RE, Sanda MG, Giehl K, et al. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 2004, 64:825-829. 10.1158/0008-5472.CAN-03-2755, 14871807.
14. Martin MD, Hilsenbeck SG, Mohsin SK, Hopp TA, Clark GM, Osborne CK, Allred DC, O'Connell P. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat 2006, 95:7-12. 10.1007/s10549-005-9016-8, 16244788.
15. Ryu SH, Chung YH, Lee H, Kim JA, Shin HD, Min HJ, Seo DD, Jang MK, Yu E, Kim KW. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 2008, 47:929-936. 10.1002/hep.22124, 18306220.
16. Kawasaki G, Yanamoto S, Yoshitomi I, Yamada S, Mizuno A. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. Int J Oral Maxillofac Surg 2008, 37:1039-1046. 10.1016/j.ijom.2008.05.020, 18640824.
17. Zhu X, Guo Y, Li X, Ding Y, Chen L. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. J Thorac Oncol 2010, 5:1159-1166. 10.1097/JTO.0b013e3181e04d98, 20661085.
18. Li SH, Tian H, Yue WM, Li L, Li WJ, Chen ZT, Hu WS, Zhu YC, Qi L. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Ann Surg Oncol 2011, 18:2048-2056. 10.1245/s10434-010-1510-5, 21290196.
19. Du B, Yang ZY, Zhong XY, Fang M, Yan YR, Qi GL, Pan YL, Zhou XL. Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J Gastroenterol 2011, 17:1219-1226. 10.3748/wjg.v17.i9.1219, 3063917, 21448429.
20. Li SH, Tian H, Yue WM, Li L, Gao C, Li WJ, Hu WS, Hao B. Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer. World J Surg 2012, 36:623-631. 10.1007/s00268-011-1421-z, 22270988.
21. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual 2010, Springer, New York, 7.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-481.
23. Cox DR. Regression models and life tables. J R Stat Soc B 1972, 34:187-220.
24. Deng Y, Zhou D, Zeng L. Expression and significance of MTA1 and RECK gene in nasopharyngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011, 25:534-538.
25. Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, et al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 2011, 103:1761-1770. 10.1093/jnci/djr432, 22056739.
26. Yoo YG, Kong G, Lee MO. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J 2006, 25:1231-1241. 10.1038/sj.emboj.7601025, 1422150, 16511565.
27. Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, Schulze-Hoepfner F, Mirochnik Y, Satcher RL, Levenson AS. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 2011, 71:268-280. 10.1002/pros.21240, 20717904.
28. Yan C, Wang H, Toh Y, Boyd DD. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J Biol Chem 2003, 278:2309-2316. 10.1074/jbc.M210369200, 12431981.
29. Zhang H, Stephens LC, Kumar R. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res 2006, 12:1479-1486. 10.1158/1078-0432.CCR-05-1519, 16533771.
30. Hofer MD, Menke A, Genze F, Gierschik P, Giehl K. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer 2004, 90:455-462. 10.1038/sj.bjc.6601535, 2409548, 14735193.
31. Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A, McMahon SB. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci U S A 2005, 102:13968-13973. 10.1073/pnas.0502330102, 1236531, 16172399.
32. Lee SH, Chung YH, Kim JA, Lee D, Jin YJ, Shim JH, Jang MK, Cho EY, Shin ES, Lee JE, et al. Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma. Liver Int 2012, 32:457-466.